Login / Signup

Cardiovascular benefits of SGLT2 inhibition in diabetes and chronic kidney diseases.

Anita T LaytonV Vallon
Published in: Acta physiologica (Oxford, England) (2018)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • insulin resistance
  • metabolic syndrome
  • drug induced
  • adipose tissue
  • skeletal muscle